Cephalon Overview

  • Founded
  • 1987
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 800
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $6.8B
Latest Deal Amount

Cephalon General Information

Description

Cephalon was a provider and developer of medicines for central nervous system disorders, pain and cancer. The company's research, development, manufacturing, and marketing activities focused on therapies for central nervous system disorders, cancer, pain and inflammatory disease. It offered its products through distributors in the United States and internationally. The company was founded in 1987 and was headquartered in Frazer, Pennsylvania.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Primary Office
  • 41 Moores Road
  • Frazer
  • Malvern, PA 19355
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cephalon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Oct-2011 $6.8B 00.00 Completed Generating Revenue
3. Merger/Acquisition 05-Apr-2011 00.00 00.00 Cancelled Generating Revenue
2. IPO 25-Apr-1991 Completed Startup
1. Early Stage VC Completed Startup
To view Cephalon’s complete valuation and funding history, request access »

Cephalon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cephalon Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ben Franklin Technology Partner of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
New Leaf Venture Venture Capital Minority 000 0000 000000 0
New Science Ventures Venture Capital Minority 000 0000 000000 0
Oak Investment Partners Venture Capital Minority 000 0000 000000 0
SR One Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Cephalon Investments & Acquisitions (20)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000000 0ü0 000 10-Jan-2012 000000000000000000 Clinics/Outpatient Services
00000 0 0000000000 01-Apr-2011 000000000000000000 00000 Pharmaceuticals
000000000 00000000 29-Mar-2011 000000000000000000 00000 Biotechnology
000000000 11-Feb-2011 0000 00000 Biotechnology
Alba Therapeutics (Larazotide Acetate Assets) 09-Feb-2011 Corporate Asset Purchase 0000 Buildings and Property 00000 00000
You’re viewing 5 of 20 investments and acquisitions. Get the full list »

Cephalon Subsidiaries (2)

Company Name Industry Location Founded
Fachklinik für Amputationsmedizin Osterhofen Clinics/Outpatient Services Osterhofen, Germany 1999
00000 Biotechnology Basel, Switzerland 0000
To view Cephalon’s complete subsidiaries history, request access »

Cephalon Exits (1)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000 000000 05-Jan-2004 00000 00000 00 00.000 Completed
  • 5 buyers
To view Cephalon’s complete exits history, request access »